Short Interest in Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Declines By 36.3%

Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 72,000 shares, a decrease of 36.3% from the March 31st total of 113,000 shares. Based on an average daily volume of 1,380,000 shares, the days-to-cover ratio is […]

Related Keywords

Thomson Reuter ,Geode Capital Management ,Aridis Pharmaceuticals Get Rating ,Aridis Pharmaceuticals ,Virtu Financial ,Zacks Investment Research ,Aridis Pharmaceuticals Inc ,Commonwealth Equity Services ,Nasdaq ,Wealth Architects ,Citadel Advisors ,Get Rating ,Equity Services ,Nasdaq Ards ,Cards ,Medical ,Stocks ,Options ,Put ,Call ,